Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
PMVS
Evaluation of a Relationship Between Driving Pressure in Pressure Support Ventilation (PSV) and Mechanical Ventilation Weaning Time on Post-ARDS Patients
1 other identifier
observational
45
1 country
1
Brief Summary
With the birth of Mechanical Ventilation in the 1950s came the ventilation induced lung injuries (VILI). Numerous works have since then shown the benefit of "protective ventilation", notably by controlling the delivered tidal volume and pressures. However, as the respiratory condition improves and the weaning is started by shifting to Pressure Support Ventilation (PSV), these parameters stop being tightly controlled. This study aims to determine whether there is a relationship between the driving pressure measured in PSV and the weaning time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2019
CompletedFirst Posted
Study publicly available on registry
September 6, 2019
CompletedStudy Start
First participant enrolled
September 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 16, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 16, 2021
CompletedJune 7, 2021
June 1, 2021
1.5 years
August 30, 2019
June 4, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ventilation free days
Ventilation free days is defined by the first transition from mechanical controlled ventilation to pressure support ventilation following a moderate to severe ARDS.
at day 28 following the inclusion visit
Secondary Outcomes (3)
Extubated patients
at day 7 after inclusion visit
Successful weaning test
from inclusion day to successful weaning test, up to 28 days
Compliance of the Respiratory System (CRS)
from inclusion day to day 7
Study Arms (1)
Experimental
Experimental group is composed by patients that enter the weaning phase following a moderate to severe Acute Respiratory Distress Syndrome (ARDS) equiped with a nasogastric allowing measures of Electrical Activity of diaphragm (EAdi) will be included. Driving Pressure will be measured following the method used by Bellani et al. A weaning test will be conducted daily.
Interventions
* Daily measures of End Inspiratory Pressure with respiratory synchronisation optimised by use of EAdi * Daily spontaneous breathing trial using low levels of pressure support * Pplat, Respiratory System Compliance, Driving Pressure, PEEP, Tidal Volume will be monitored daily as well as clinical and other routine ventilatory data. Data concerning initial severity of ARDS, and duration of ARDS, controlled mechanical ventilation, sedation and neuromuscular blockade and date of first spontaneous breathing trial will be collected. A weaning test will be conducted daily.
Eligibility Criteria
Patients hospitalized in the thoracic resuscitation department of the Haut-Lévêque Hospital, Bordeaux University Hospital, who will be consecutive patients undergoing respiratory weaning following a moderate-to-severe ARDS according to the Berlin criteria, and not presenting the exclusion criteria mentioned above will be proposed the protocol.
You may qualify if:
- Patient over 18 years old
- Patients hospitalized in the ICU and who have suffered moderate to severe ARDS (Berlin criteria) equiped with nasogastric feeding tube allowing measures of Eadi
You may not qualify if:
- COPD or measured or suspected auto-PEEP higher than 3 cmH2O at beginning of Pressure Support
- Admission in the ICU more than 15 days before the initiation of weaning
- Broncho-pleural leaks
- ECMO
- Pregnant woman.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Haut-Lévêque
Pessac, 33604, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 30, 2019
First Posted
September 6, 2019
Study Start
September 27, 2019
Primary Completion
March 16, 2021
Study Completion
March 16, 2021
Last Updated
June 7, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share